Loading...
Implications of Immunotherapy in Hepatobiliary Tumors
Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related death worldwide. Upon ineligibility for resection, liver transplantation, or locoregional therapies, sorafenib has been the only systemic treatment option of advanced HCC for more than a decade. Immunotherapy is an ev...
Saved in:
| Published in: | Visc Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
S. Karger AG
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6597927/ https://ncbi.nlm.nih.gov/pubmed/31312646 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000496755 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|